Design, Formulation and Evaluation of Piroxicam Capsules Prepared by Solid Dispersion Technique

References (44)

1. 1 Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices [DOI]
2. 2 Improving drug solubility for oral delivery using solid dispersions [DOI]
3. 3 Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs [DOI]
4. 4 Analytical profiles of drug substances [DOI]
5. 5 The mechanisms of drug release from solid dispersions in water-soluble polymers [DOI]
6. 6 Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man. [DOI]
7. 7 Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers [DOI]
8. 8 Properties of solid dispersions of piroxicam in polyvinylpyrrolidone [DOI]
9. 9 Drug delivery to the upper small intestine window using gastroretentive technologies [DOI]
10. 10 A curved multi-component aerosol hygroscopicity model framework: Part 1 – Inorganic compounds [DOI]
11. 11 Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30 [DOI]
12. 12 Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques [DOI]
13. 13 Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process [DOI]
14. 14 Development, characterization and stabilization of amorphous form of a low Tg drug [DOI]
15. 15 Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone [DOI]
16. 16 Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation [DOI]
17. 17 Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam [DOI]
18. 18 Effect of a melt agglomeration process on agglomerates containing solid dispersions [DOI]
19. 19 Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent [DOI]
20. 20 Bioavailability enhancement of an active substance by supercritical antisolvent precipitation [DOI]
21. 21 Improved dissolution of ofloxacin via solid dispersion [DOI]
22. 22 A three step supercritical process to improve the dissolution rate of Eflucimibe [DOI]
23. 23 A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions [DOI]
24. 24 Solution Structures of Chromium(VI) Complexes with Glutathione and Model Thiols [DOI]
25. 25 Physicochemical Characterizations of Piroxicam-Poloxamer Solid Dispersion [DOI]
26. 26 Preformulation study of etoposide: II. Increased solubility and dissolution rate by solid-solid dispersions [DOI]
27. 27 Enhancement of Dissolution and Bioavailability of Piroxicam in Solid Dispersion Systems [DOI]
28. 28 Improving Dissolution of Meloxicam Using Solid Dispersions [DOI]
29. 29 Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000: preparation and in vitro evaluation [DOI]
30. 30 Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method [DOI]
31. 31 Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry [DOI]
32. 32 The dissolution of nortriptyline HCl from polyethylene glycol solid dispersions [DOI]
33. 33 Dissolution properties of polyethylene glycols and polyethylene glycol-drug systems [DOI]
34. 34 Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor [DOI]
35. 35 An investigation into the mechanisms of dissolution of alkyl p-aminobenzoates from polyethylene glycol solid dispersions [DOI]
36. 36 Influence of wetting factors on the dissolution behavior of flufenamic acid. [DOI]
37. 37 Enhanced dissolution and bioavailability of gliclazide using solid dispersion techniques. [DOI]
38. 38 Crystal Structure Transformations and Dissolution Studies of Cimetidine–Piroxicam Coprecipitates and Physical Mixtures [DOI]
39. 39 Formulation of furosemide solid dispersion with micro crystalline cellulose for achieve rapid dissolution [DOI]
40. 40 Oxicams: Metabolic Disposition in Man and Animals [DOI]
41. 41 Improvement of water solubility and dissolution rate of ursodeoxycholic acid and chenodeoxycholic acid by complexation with natural and modified β-cyclodextrins [DOI]
42. 42 Preparation and Evaluation of Piroxicam–HPMCAS Solid Dispersions for Ocular Use [DOI]
43. 43 Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
44. 44 STUDY OF THE INCLUSION COMPLEXATION OF PIROXICAM - B- CYCLODEXTRIN AND DETERMINATION OF THE STABILITY CONSTANT (K) BY DV-VISIBLE SPECTROSCOPY

Cited by 6

Showing 5 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Studies on Target-specificity and Biological Activity of Streptococcus Serum Antibody and Sulfate Amikacin Conjugates — shares topic coverage
• Growth Increment of Tissue Cultured Abaca Seedlings Applied with Conventional Fertilizer and Biostimulant — shares topic coverage
• Assessment of Wheat Genotypes for Drought Tolerance Using PEG 6000 — shares topic coverage
• Effect of PEG-Mediated Water Deficit on Morphometric Traits and Antioxidants Activity in Chickpea Plants — shares topic coverage
• Rapid Screening of Small Millet Varieties for Seedling Stage Drought Stress Tolerance — shares topic coverage